WebJun 13, 2024 · lundi 13 juin 2024 à 13h25. (CercleFinance.com) - Medesis Pharma annonce les premières inclusions de malades dans l'essai clinique de phase II de son programme NanoLithium -formulation ... WebApr 5, 2024 · (Reuters) -French biotech company Medesis Pharma has requested defence funding to speed up the development of three drugs to treat nuclear contamination, it said on Tuesday, sending its shares up by as much as 75% in early trading. Medesis said it had requested funding from France's Defence Innovation Agency for three drugs "specifically …
MEDESIS PHARMA LANCE SON INTRODUCTION EN BOURSE SUR
WebMedesis Pharma will be at the annual meeting of EDHN, a non-profit research network dedicated to advancing research, facilitating the conduct of clinical trials, and improving the clinical management of Huntington's Disease, from September 16 to 18. Medesis Pharma is developing a genetic treatment program for Huntington's disease combining RNA … WebJan 26, 2024 · L'introduction en Bourse de MEDESIS PHARMA bénéficie d'engagements de souscription d'investisseurs financiers pour un montant de 3,9 M€ et de 1,4 M€ de la part … ruth may chief nursing officer email
Medesis Pharma (biotech) en Bourse : modalités IPO, prix, …
WebAu cours du 1er semestre 2024, il a été négocié un total de : ACHAT 26 330 titres 252 269,81 € 435 transactions ... Les actions de Medesis Pharma sont cotées sur Euronext Growth Paris. FR0010844464 - ALMDP Pour plus d’information : www.medesispharma.com MEDESIS PHARMA WebJan 26, 2024 · Montpellier, le 26 janvier 2024 – MEDESIS PHARMA, société de biotechnologie pharmaceutique, annonce le lancement de son introduction en Bourse en … WebMedesis Pharma. 2,626 followers. 3mo. Medesis Pharma will be at the annual meeting of EDHN, a non-profit research network dedicated to advancing research, facilitating the … ruth may email address